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INTRODUCTION
Spontaneous DNA damage arising from hydrolytic decay occurs at a rate of well over 20,000 modifications per cell per day [Lindahl, 1993] . This includes deamination of cytosine to uracil and the release of base residues to generate abasic sites. In addition, endogenous DNA damage is created by attack of reactive oxygen or nitrogen species, which are byproducts of mitochondrial respiration, and intracellular alkylative compounds, such as S-adenosylmethionine. A range of exogenous sources, such as chemical and physical agents, including sunlight and ionizing radiation, can also introduce DNA lesions through direct and indirect mechanisms. If DNA damage persists, it has the ability to promote mutagenic outcomes, including base substitutions or gross chromosomal rearrangements, mainly during replication, or to activate responses that lead to cell death.
The base excision repair (BER) pathway is one of five major DNA repair mechanisms that function to maintain genome stability and prevent disease development, such as cancer or premature aging phenotypes [Brenerman et al., 2014] . In particular, BER operates to clear an array of base modifications, apurinic/apyrimidinic (AP) sites, and single-strand breaks from the genome. During classic BER, damaged bases are excised by a lesion-specific DNA glycosylase, which cleaves the N-glycosidic bond to remove the substrate base, generating an AP site product. Incision of the DNA backbone at the AP site is often performed by an AP endonuclease, such as APE1 in mammals. In its most simplistic form, mammalian BER continues with base incorporation and 5 0 -AP residue excision through the repair activities of DNA polymerase b (POLb). Finally, a complex of ligase 3, isoform a (LIG3a) and X-ray cross-complementing protein 1 (XRCC1) operates to seal the nick, although alternative subpathways exist that can engage specialized processing enzymes and/or factors with ties to replication [Fortini and Dogliotti, 2007; Wilson et al., 2011] . Failure to execute BER efficiently has been associated with developmental issues, immunodeficiency, neurological abnormalities, and cancer susceptibility.
APE1 is the major AP endonuclease in mammalian cells and shares gene and protein homology with Escherichia coli exonuclease III (Xth) (see review [Li and Wilson, 2014] ). APE1 has multiple DNA repair functions, with its primary role being to operate as an AP endonuclease in BER. However, the enzyme also exhibits 3 0 -phophodiesterase, 3 0 -phosphatase, 3 0 -5 0 exonuclease, RNase H, and RNA cleavage activities; these functions presumably contribute to singlestrand break repair, DNA synthesis proofreading, and mRNA pool cleansing. The N-terminus of mammalian APE1, which is not conserved in the bacterial protein Xth, contains residues that contribute to its so-called REF-1 function [Xanthoudakis and Curran, 1992; Xanthoudakis et al., 1994] . In this capacity, APE1 has the ability to stimulate the DNA binding activity of certain transcription factors (e.g., AP-1, Egr-1, p53, NF-jB), thereby affecting gene expression efficiencies through a mechanism involving protein reduction (see review [Kelley et al., 2012] ). APE1 appears to contribute to transcriptional regulation via other means as well, such as through its capacity to bind ca responsive-elements [Okazaki et al., 1994; Antoniali et al., 2014] . Notably, APE1 is ubiquitously expressed in all tissue and cell types, and genetic knockout (KO) in mice leads to embryonic lethality, underscoring the critical nature of the multifunctional protein [Xanthoudakis et al., 1996] . Haploinsufficient APE1 mice have been reported to display normal life expectancy, but impaired survival, elevated mutation rates, increased sensitivity to oxidative stress, and a higher incidence of tumor formation [Meira et al., 2001; Huamani et al., 2004; Unnikrishnan et al., 2009] , indicating that deficiencies in APE1 can lead to disease susceptibility. In addition, several studies have found that APE1 expression and/or localization is altered in a disease-dependent manner. For example, studies have found that high expression, or a cytoplasmic or cytoplasmic/nuclear redistribution, of APE1 can correlate with DNA-damaging agent resistance, tumor aggressiveness, or cancer patient prognosis (see reviews [Abbotts and Madhusudan, 2010; Li and Wilson, 2014] ). Our previous studies found that naturally occurring polymorphic variants of APE1, that is, Q51H, I64V, and D148E, do not exhibit impaired function or cellular localization in biochemical and cell-based experiments [Illuzzi et al., 2013] . In addition, the rare population variants, G241R and A317V, as well as the somatic cancer-associated variant P311S, similarly showed normal functions for several end-points examined. However, the variant R237C, reported as a somatic mutation in a single case of endometrial cancer, was observed to have an approximately twofold reduced AP-DNA complex stability (although a normal AP site incision activity), an approximately threefold reduced 3 0 -exonuclease processing activity, and about a twofold reduced ability to access AP sites within the context of chromatin [Illuzzi et al., 2013; Hinz et al., 2015] . To further interrogate the potential role of APE1 in disease development, we examined (i) the complementation efficiency of the R237C variant, (ii) the consequence of overexpression of either wild-type (WT) or R237C APE1, and (iii) the effect of targeted APE1 deletion on a range of cellular phenotypes using genetically defined mouse and human cell-based models.
MATERIALS AND METHODS

APE1Expression Plasmids
Green fluorescent protein (GFP)-tagged expression plasmids were generated for both the WT and R237C human APE1 protein. In brief, Environmental and Molecular Mutagenesis. DOI 10.1002/em
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the APE1 coding region was amplified from the appropriate pET11a-APE1 expression plasmid [Illuzzi et al., 2013] using primers: 5 0 -CCCCAAGCTTTAATGCCGAAGCGTGG-3 0 (5 0 HINDIII) and 5 0 -CGGG ATCCTCACAGTGCTAGGTATAGG-3 0 (3 0 BAMHI). The polymerase chain reaction (PCR) product was purified and subcloned into the HindIII and BamHI restriction sites of the pAcGFP vector (Clontech, Palo Alto, CA) to create N-terminal GFP-tagged fusion proteins. Each vector was sequence confirmed at the Johns Hopkins University sequencing facility (Baltimore, MD).
Complementation of APE1-Deficient Mouse Cells
To generate conditional APE1 (a.k.a. APEX1) KO cells, coding exons 2 and 3 were flanked with LoxP sites via recombineering. Subsequently created transgenic mice harboring floxed APE1 alleles (further details to be published elsewhere) were then crossed with mice possessing a tamoxifen (TM)-inducible Cre recombinase expression cassette under the control of a chicken b-actin promoter [Hayashi and McMahon, 2002] (strain designated CAGGCre-ER; The Jackson Laboratory, stock number 004453). Primary mouse embryonic fibroblasts (MEFs), which harbored both the floxed APE1 alleles and the TM-inducible Cre recombinase system, were isolated from these transgenic mice and transfected with the different GFP expression plasmids noted above using the Amaxa Nucleofector System (Lonza) and MEF 1 Nucleofector Kit (Lonza) following the T-20 protocol. After transfection, MEFs were placed under hygromycin B selection (0.25 mg/mL) for 3 days, before being exposed to TM at the indicated concentration for the indicated time. In the cell survival studies, TM was used at 5 lM and exposure occurred for 96 hr. For methyl methanesulfonate (MMS) sensitivity, 5,000 cells per treatment group were placed into the target well of a 96-well plate. Cells were allowed to adhere and were then exposed to MMS at concentrations of 0, 0.5, 1, 1.5, 2, and 2.5 mM for 1 hr at 378C. Cells were washed with 13 phosphate buffered saline (PBS) twice and incubated for an additional 48 hr. A Cell Counting Kit-8 (Dojindo) was used to determine cell proliferation and viability. In brief, 10 mL of the CCK-8 solution was added to each assay well and incubated for 3 hr at 378C. The plate was then analyzed (abs 450 nm) using a Benchmark Plus spectrophotometer (Bio-Rad, Richmond, CA). Cell survival ratio was determined relative to the untreated control. For the long-term cell viability studies, the same procedure was used, except after transferring the 5,000 cells to each target well, cells were allowed to rest for 2 hr prior to conducting the CCK-8 assay.
Creation of Doxycycline-Responsive C127I Cell Line C127I cells, which are a nontransformed clonal line derived from a murine mammary tumor, were obtained from American Type Culture Collection. Cells were maintained in high glucose Dulbecco's modified Eagle's media (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS, Invitrogen), 100 U/mL penicillin, and 100 U/mL streptomycin (Invitrogen) at 378C with 5% humidity. To obtain C127I cells with the Tet-controlled transactivator protein (tTA-Advanced; tTA-A), a monolayer of cells at 80% confluency was infected with a packaged retrovirus (see Clontech Retro-X Tet-Off Advanced system) in the presence of 4 mg/mL polybrene at 378C overnight. The next day, cells were trypsinized and split 1:5 into new 100-mm plates in full growth media with 400 mg/mL G418 (Invitrogen) and grown until individual colonies could be isolated using 8 mm cloning cylinders. Individual clones were placed in 24-well plates and expanded into independent cell lines. After two passages, cells were grown in the presence of doxycycline (Dox) and maintained without G418. Once established cell lines were expanded, each line was then screened for the presence of the tTA-A protein using Western blot and the TetR antibody purchased from Clontech (see Results section).
Creation of Dox-Regulated APE1C127I Cell Lines DNA constructs were prepared by subcloning the cDNAs for WT human APE1or R237C into the pRetroX-Tight-Pur vector from Clontech. To generate Dox-regulated cell lines, the tTA-A clone TO7 line (see Results section) was infected as above with packaged retrovirus (Clontech) for each gene of interest: WT and R237C. Selection was performed in a similar fashion as above using 2.5 mg/mL puromycin. Confirmation of the empty vector (RX) cell line was performed by isolating genomic DNA and executing PCR using the following primers: Forward, 5 0 -ATCTGAGGCCCTTTCGTCTTCACT-3 0 , and reverse, 5 0 -TGTGT GCGAGGCCAGAGGCCACTT-3 0 to confirm the presence of integrated DNA (data not shown).
Creation of HCT116 APE1 Heterozygous KO Cell Line HCT116 cells were maintained in McCoy's 5A media with L-glutamine (Invitrogen) supplemented with 10% FBS (Invitrogen), 100 U/mL penicillin, and 100 U/mL streptomycin (Invitrogen) at 378C with 5% humidity. The human APE1 locus was targeted by a KO construct containing a neomycin-resistance marker flanked by two regions of genomic homology, packaged in a recombinant adeno-associated virus [Topaloglu et al., 2005] .
Genomic DNA was isolated from HCT116 cells using the Qiagen DNeasy Blood and Tissue kit. PCR was performed on the purified DNA to generate the left homology arm using the following primers (underline designates the human genome sequence): 5 0 APE1KOL_Asc1, 5 0 -AGGCGCGCCCTCTGATCACGTGACCAGGTC23 0 and 3 0 APE1KOL_ SpeI, 5 0 -GGACTAGTAAATACAACTGGCAAGACTGG23 0 . The right homology arm was created using: 5 0 APE1KOR_EcoRI, 5 0 -GGAATTC GAACTCTTCAAAACCAATTGC23 0 and 3 0 APE1KOR_XhoI, 5 0 -CCGCTCGAGGGGACTTATCCTGTGCTTG23 0 . Purified PCR products were directionally ligated into complementary restriction sites in the AAV-SEPT plasmid [Rago et al., 2007] to create the targeting construct, APE1 KO-SEPT. Infectious virus was produced according to Rago et al. [2007] and used to infect HCT116 cells. After 24 hr, cells were trypsinized and split 1:5 into 100 mm dishes. Cells were grown in the above media supplemented with 200 mg/mL G418 (Invitrogen) for 1 week at 378C. Geneticin-resistant colonies were isolated using sterile cloning cylinders and expanded in normal growth media. Genomic DNA was isolated from these subclones (DNeasy Blood and Tissue Kit, Qiagen), and PCR was conducted to assess homologous integration of the targeting construct into the APE1 locus. The PCR primer pairs were designed so that one would anneal outside the homology region and the other would be specific for the selectable marker. The primers used were: Forward, Seq A (within SEPT sequence): 5 0 -ATTTGATATTCACCTGGCCCGC-3 0 ; Reverse, Seq B (downstream of exon 5): 5 0 -TTGCTGCTGCT ATTGCACTTCACC-3 0 ; Forward, Seq C (upstream of exon 1):
0 (before the translation start site within exon 1); and R1 (internal to exon 5): 5 0 -GGGACTTATCCTGTGCTTG-3 0 . Homologous integration was assessed across the left homology arm using primer sets of C or F1 with D, R1 or B; across the right homology arm using primers B or R1 with A, C or F1; and insertion of the SEPT sequence using primer A with R1 or B.
Western Blotting
Total cell extracts were prepared using 13 radioimmunoprecipitation assay (RIPA) buffer with 13 Halt protease inhibitor cocktail (Pierce). Cells were lysed for 30 min on ice, and the solution was centrifuged for 15 min at 18,000g at 48C. The supernatant was transferred to a new tube, and protein concentrations were determined using either a Bradford assay (Bio-Rad) or the BCA protein assay kit (Thermo Scientific) in Environmental and Molecular Mutagenesis. DOI 10.1002/em combination with bovine serum albumin (BSA) to generate the standard curve. After quantitation, protein samples (as indicated) were separated on a polyacrylamide-SDS gel and transferred to a polyvinylidene fluoride membrane. The membrane was blocked with 5% (w/v) milk in 13 Tris-buffered saline (TBS) containing 0.1% (w/v) Tween-20 (TBST) for 1 h and then probed overnight at 48C with a tTA-A monoclonal antibody (1:1,000, Clontech) or an in-house rabbit polyclonal antibody to APE1 (1:1,000). The membrane was washed three times using TBST and incubated with secondary antibody (1:5,000, anti-mouse, goat-horseradish peroxidase (HRP) or anti-rabbit, goat-HRP, Pierce) at room temperature for 1 hr, before washing as above and visualizing with SuperSignal West Femto Chemiluminescent kit (Thermo Scientific) or the ECL Plus detection kit (Pierce) on a ChemiDoc XRS 1 (Bio-Rad).
Immunofluorescence and Imaging
Once cells reached passage 5 ($14 days) with or without Dox treatment, they were plated at 1 3 10 5 per well in four-well glass slide chambers and grown for 24 hr at 378C. Cells were then washed with 13 PBS, fixed with 4% paraformaldehyde at room temperature for 30 min, permeabilized with 0.5% Triton-X in PBS at room temperature for 10 min, blocked with 10% goat serum for 30 min at room temperature, and incubated with the in-house APE1, rabbit polyclonal antibody (1:500 dilution in PBS plus 10% milk) overnight at 48C. After incubation, cells were washed three times with 0.1% Triton-X in PBS at room temperature. The 488-labeled, secondary antibody (anti-rabbit, goat, 1:500, Invitrogen), in PBS plus 10% milk, was added for 1 hr at room temperature. Cells were washed as above, before the addition of Vectashield Mounting Medium with 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories). Cells were visualized by fluorescent microscopy, and image analysis was performed with Velocity 6 software (Perkin Elmer).
AP Site Incision
Whole cell extracts were prepared by resuspending cell pellets in a hypotonic buffer (0.5 mM Tris, pH 7.1, 1 mM ethylenediaminetetraacetic acid (EDTA), 0.5 mM spermidine, 0.1 mM spermine, 0.5 mM dithiothreitol (DDT), and 13 Halt protease inhibitor cocktail (Pierce)). The cell solution was stored overnight at 2808C and thawed quickly the next day at 308C. After thawing, the solution was brought up to 222 mM KCl and incubated on ice for 30 min. After incubation, the solution was centrifuged at 15,000g for 15 min at 48C. The supernatant was transferred to a clean tube, and glycerol was added to a final concentration of 10%. Protein concentrations were determined as described above, and extracts were stored at 2808C. Incision assays were performed at the indicated concentrations of whole cell extract with 13 reaction buffer (50 mM Tris, pH 7.5, 25 mM NaCl, 1 mM MgCl 2 , 1 mM DTT, 0.01% Tween-20) and 1 pmol of 5 0 -[ 32 P]-labeled double-stranded DNA, with the labeled strand harboring the AP site analog tetrahydrofuran, in 10 mL reactions. Reactions were incubated at 378C for 15 min, before an equal volume of stop buffer was added (90% formamide, 20 mM EDTA). Reactions were heated to 958C for 10 min before separation on a 20% polyacrylamide-urea denaturing gel. The substrate and product bands were visualized and quantified by a Typhoon Trio1 Variable model Imager (Amersham Bioscience/GE Healthcare) using the ImageQuant software to determine percent conversion.
Cell Proliferation and Cell Cycle Analysis
Cells (approximately passage 5) were plated at known densities and allowed to grow at 378C for 48 hr. When the cells reached 90% confluency, they were counted and cell doubling was determined using Doubling Time online calculator. Cell cycle analysis was performed by modifying procedures originally described in Kopp and Wersto [1992] . At the time of harvesting, the growth media was saved, cells were washed and trypsinized, and the original growth media was used to resuspend the cells. This process allows for any floating, mitotic cells to be included in the analysis population. Cells were centrifuged at 1,500g for 5 min at 48C. The supernatant was aspirated, and cells were resuspended in 500 mL FBS and stored at 2708C until staining. For analysis of DNA content, thawed samples were mixed with an equal volume of detergent buffer, pH 7.4 (137 mM NaCl, 5.4 mM KCl, 0.5 mM KH 2 PO 4 , 0.3 mM Na 2 H-PO 4 Á7H 2 O, 1.3 mM CaCl 2 , 0.5 mM MgCl 2 Á6H 2 O, 0.4 mM MgSO 4 Á7H 2 O, 23.5 mM HEPES, 30 mM BSA, and 0.4% Nonidet P-40, and 50 lg/mL propidium iodide), followed by the addition of 15 mL of 0.5 M RNase (Sigma). The samples were mixed and incubated in the dark for 1 hr before analysis. DNA content was measure on a FACSCanto flow cytometer (Becton-Dickinson), and DNA histograms were deconvoluted into cell cycle phases using Multicycle (Phoenix Flow).
DNA Damage Assays
The level of AP sites for each cell line was determined using the Dojindo DNA damage quantification kit (Dojindo Molecular Technologies). In brief, approximately 2 3 10 6 cells were harvested, centrifuged, and washed in 13 PBS. Genomic DNA was isolated using the DNeasy Blood and Tissue kit (Qiagen), and the optical density was determined using a Nanodrop spectrophotometer (Thermo Fisher Scientific) before AP sites were measured. Comet assays were performed by harvesting 1 3 10 5 cells, washing them in 13 PBS, and then centrifuging and resuspending the cells in 100 mL 13 PBS. Using the basic protocol described in Gutzkow et al. [2013] , 4 mL of 0.6% low melting point agarose minigels were cast at approximately 20 cells per minigel, with eight minigels per sample. The gels were cooled briefly to 48C and lysed overnight in neutral conditions (2.5 M NaCl, 100 mM EDTA, 10% v/v DMSO, 10 mM Tris, 1% v/v Triton 100X). Gels were then washed in 13 Tris/Borate/EDTA (TBE) for 30 min, and electrophoresis was performed in a shallow gel box in fresh 13 TBE at 25 V for 22 min. Cells were imaged and scored after staining in 13 SYBR Gold using Comet Assay IV software (Perceptive Instruments).
Mitochondrial Parameters
Protocols were adapted from Fang et al. [2014] . Cells were plated to reach 80% confluency after 24 hr at 378C. After all solutions were heated to 378C, cells were harvested, centrifuged, washed in 13 PBS, and resuspended in appropriate solutions depending on the measurement. To determine mitochondrial content, 50 nM MitoTracker Green (Life Technologies) was used for 30 min at 378C. To determine membrane potential, cells were incubated with tetramethylrhodamine methyl ester (TMRM, Sigma) for 15 min at 378C. To determine levels of reactive oxygen species (ROS), cells were resuspended in a solution containing 5 mM MitoSOX Red (Life Technologies) and incubated for 10 min at 378C. Fluorescence of all samples was determined by flow cytometry (BD Accuri C6), and data analysis was performed using FlowJo (Ashland, OR).
Transformation Assays
Assays to measure cellular transformation were adapted from protocols in Sweasy et al. [2005] . All cells were grown at 378C for the designated passage lengths, then submitted to analysis. The soft agar transformation assay was performed using the 96-well standard soft agar kit from Cell Biolabs (San Diego, CA); the following protocol and solutions follow the kit provided by Cell Biolabs. In a 96-well plate, the base agar layer was prepared using equal parts of a 1.2% agar solution and 23 DMEM/20% FBS medium (Cell Biolabs). After the base agar layer was solidified and then warmed to 378C, a cell suspension was prepared by harvesting cells and resuspending 1 3 10 5 cells in growth media. Subsequently, the cell agar layer was prepared by mixing equal parts 1.2% agar/23 DMEM/20% FBS (Cell Biolabs) and the above cell suspension. The cell agar layer was then solidified on top of the base agar layer, and 100 mL of media, with or without Dox, was added, and the cells were grown for 1 week at 378C, adding more media as necessary. After 1 week, the media was removed, Environmental and Molecular Mutagenesis. DOI 10.1002/em
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and the agar solubilization solution was added for 1 hr at 378C. Afterward, the 83 lysis buffer (Cell Biolabs) was added, and the mixture was incubated at room temperature for 15 min. In a black, clear-bottom 96-well plate, 10 mL cell lysate was mixed with 90 mL CyQuant working solution (Cell Biolabs) and incubated for 10 min at room temperature. The plate was read using the BioRad Benchmark Plus microplate reader and spectrophotometer at 485/520 nm to determine absorbance of the fluorescent dye. Focus formation was performed by plating 1,000 cells in T-25 flasks with or without Dox. Cells were supplemented with more growth media every 3-4 days, as needed. After 2 weeks, cells were stained with a crystal violet solution (0.5% crystal violet in 50% methanol) for 15 sec before washing in distilled water. Flasks were air dried and the number of foci counted.
DNA-Damaging Agent Exposure and Cell Viability
HCT116 cells were plated at 5,000 cells per well in a 96-well plate, grown overnight at 378C, and then treated the next day with varying doses of H 2 O 2 or MMS for 1 hr. After incubation, the cells were allowed to recover for 23 hr prior to assessing viability, which was measured by using the CCK-8 Viability Assay (Dojindo Molecular Technologies). In brief, 10 mL of the CCK-8 solution was added to the culture, and the plate was placed back in the 378C incubator for 3 hr. The optical density was then measured at 450 nm using the microplate reader, and the results plotted relative to the untreated control.
Microarray Analysis
RNA was prepared from the identified samples using Qiagen RNeasy Mini kit per the manufacturer's instructions. Using the Illumina TotalPrep RNA Amplification Kit, total RNA was first converted into single-stranded cDNA with reverse transcriptase using an oligo-dT primer containing the T7 RNA polymerase promoter site and then copied to produce doublestranded cDNA. The double-stranded cDNA was purified and concentrated with the supplied columns and used in an overnight in vitro transcription reaction to generate single-stranded RNA (cRNA) harboring biotin-16-uridine triphosphate (UTP). A total of 0.75 mg of biotin-labeled cRNA was hybridized at 588C for 16 hr to human HT-12 v1.0 gene expression BeadChips (Illumina, San Diego, CA). Each BeadChip has 48,000 wellannotated RefSeq transcripts with approximately 30-fold redundancy. The arrays were washed, blocked, and the labeled cRNA was detected by staining with streptavidin-Cy3. Hybridized arrays were scanned using an Illumina BeadStation 500X Genetic Analysis Systems scanner, and the image data were extracted using the Illumina GenomeStudio software, version 1.1.1.1. Raw microarray data were log transformed to yield z-scores. The z-ratio was calculated as the difference between the observed gene z-scores for the experimental and the control comparisons, and dividing by the standard deviation associated with the distribution of these differences. Z-ratio values of 61.5 were chosen as cut-off values and calculated using a 5% false discovery rate threshold. A complete set of 522 cellular pathways was obtained from the Molecular Signatures Database (MSigDB, Broad Institute, Massachusetts Institute of Technology, MA). The complete set was tested for Geneset enrichment using parametric analysis of gene set enrichment [Kim and Volsky, 2005] . For each pathway z-score, a P-value was computed using JMP 6.0 software to test for the significance of the zscore obtained. The microarray data have been deposited in Gene Expression Omnibus (GEO accession: GSE60911).
RESULTS
Reduced Complementation by the R237C Tumor-Associated Variant
Our previous work has found that the endometrial cancer-associated R237C APE1 variant exhibits impaired AP-DNA complex stability, 3 0 -exonuclease activity and ability to incise at AP sites in the context of preformed protein-DNA complexes [Illuzzi et al., 2013; Hinz et al., 2015] . To examine whether R237C might represent a reduced-function susceptibility allele, we determined its ability to complement APE1-deficient mammalian cells. MEFs that harbor a floxed APE1 allele and a TMinducible Cre-expression cassette, from here on referred to as APE1 L/L TM-Cre cells, were created (see Materials and Methods section). Initial analysis focused on determining conditions in which the addition of TM to the medium would delete both APE1 alleles in the APE1 L/L TM-Cre cells. In these experiments, Western blotting for APE1 protein expression was used to assess Cre-mediated APE1 excision at varying doses of TM at 48 or 96 hr postexposure. These studies revealed that 5 lM TM at 96 hr reproducibly resulted in no detection of APE1 protein in extracts from APE1 L/L TM-Cre cells, whereas this treatment had no effect on the APE1 levels in WT MEFs (Fig. 1A) .
Having established the TM treatment conditions to eliminate endogenous APE1 expression in APE1 L/L TMCre cells, we determined the complementation effectiveness of the tumor-associated R237C variant relative to WT APE1 and the vector control. Following transfection of the pAcGFP control plasmid, or the WT APE1 or R237C GFP-fusion construct, the APE1 L/L TM-Cre cell population was placed under hygromycin B selection for 3 days (to enrich for the plasmid), before a subset of cells was analyzed for GFP expression by fluorescence microscopy (transfection efficiency was determined to be roughly 90% for each vector). Cell imaging revealed that R237C exhibited a similar, albeit distinct, intracellular distribution in comparison to WT APE1, with nuclearspecific targeting, but reduced nucleolar localization ($27% reduced relative to WT; quantified in Supporting Information Fig. S1 ); the GFP fusion alone displayed the typical diffuse intracellular pattern (Fig. 1B) .
After the 3 day hygromycin selection step, the surviving cells were treated with TM at a final concentration of 5 lM for 96 hr to promote Cre-mediated excision of both APE1 alleles. Cells were then either tested for MMS sensitivity or monitored for growth over the course of at least 12 days. As shown in Figure 1C , relative to WT APE1, R237C provided incomplete rescue of the pronounced MMS sensitivity exhibited by the vector control cells. Moreover, R237C showed an even more dramatic impaired capacity to promote normal cell growth in comparison to the WT-corrected APE1-deficient MEFs (Fig.  1D ). These observations are seemingly in line with the impaired biochemical functions previously reported for the tumor-associated R237C variant protein, namely its inability to efficiently access AP sites in the context of chromatin, and may also suggest important nucleolar Environmental and Molecular Mutagenesis. DOI 10.1002/em contributions of APE1, particularly with regards to cell survival.
Creation of Inducible APE1-Overexpressing Cell Lines
Prior work by Sweasy and colleagues has demonstrated that expression of certain tumor-associated or population missense variants in proteins of BER, such as POLb, thymine DNA glycosylase, and endonuclease III-like glycosylase (NTH1), can promote transformation of mouse C127I cells [Sweasy et al., 2005; Galick et al., 2013; Sjolund et al., 2014] , a nontransformed clonal line derived from a murine mammary tumor. Given the relationship of altered APE1 expression and cancer, and the association of the R237C variant with a single case of endometrial cancer, we sought to determine whether overexpression of the WT protein or R237C could drive cancer cell phenotypes in C127I.
Toward that end, we first established a C127I cell line that expressed the transactivator protein tTA-A, which in the absence of Dox will bind Tet-responsive elements and promote downstream gene expression (see overview in Supporting Information Fig. S2 ). In the presence of Dox, tTA-A will be bound by the antibiotic, resulting in an inactive protein and no target gene expression. Following transduction and selection for cells harboring the pRetroX-Tet-Off Advanced vector (see Materials and Methods section), several independent G418-resistant C127I cell lines were isolated, expanded, and examined for expression of tTA-A by Western blot analysis (Supporting Information Fig. S2, Step 1) . Two lines were found to express detectable levels of tTA-A (clones TO6 L/L TM-Cre MEFs. To determine conditions that promote APE1 deletion, TM was added at 0, 1, 2.5, or 5 mM for either 48 (top) or 96 (bottom) h. Ten lg of whole cell extract was separated on a 12% polyacrylamide gel, transferred to a polyvinylidene fluoride membrane, and then probed for either APE1 or lamin. The APE1:lamin ratio is specified below each lane. (B) Intracellular localization of WT and R237C GFP-tagged APE1 proteins. Following transfection of the indicated plasmid into APE1 L/L TM-Cre MEFs, an aliquot of cells was examined visually 3 days after hygromycin B selection on a Nikon Eclipse TE2000-E microscope equipped with a CCD camera (Hamamatsu) and a green fluorescence module. Velocity software (Improvision, PerkinElmer) was used to capture and process images, which were acquired using identical gain, exposure, sensitivity and contrast settings. At least 50 cells from several independent runs were visualized for each transfection subset. Complementation of MMS sensitivity (C) or cell viability (D) by R237C. After TM-induced (5 mM at 96 h) Cre-mediated excision of the endogenous APE1 alleles (designated day 0), WT APE1-, pAcGFP vector-, or R237C-complemented APE1-deficient MEFs (designated in panel C for both panel C and D) were exposed to the indicated concentration of MMS and assessed for cell viability using the CCK-8 assay. The same assay was also used to determine cell growth (viability) at the indicated day post-exposure to TM (post-TM). For each data set, at least eight measurements were taken from two experimental runs. Shown are the averages and standard deviations of the results, plotted relative to the day 0 time point. The paired t-test was performed to compare WT versus R237C cells, and statistically significant differences are indicated: **P < 0.005.
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Consequences of Altered APE1Function
and TO7), with C127I TO7 being selected as the parental line for the subsequent experiments.
We next established C127I Tet-off (TO, i.e., gene expression off in the presence of Dox) cell lines that produce either WT human APE1 or the human R237C variant in a Dox-regulated manner (Supporting Information  Fig. S2, Step 2) . We also created a pRetroX-Tight-Pur-GOI vector control cell line (RX) for comparative purposes. Again, following transduction and selection (see Materials and Methods section), puromycin-resistant clonal cell lines were isolated and characterized. First, we determined exogenous human APE1 expression at various time points (days) after Dox removal, monitoring protein expression by Western blot analysis. We note that the primary antibody used in the conditions described herein did not efficiently cross-react with the endogenous mouse protein, allowing us to selectively monitor human APE1 expression by western blotting. As seen in Figure 2A (quantified in Supporting Information Fig. S3 ), exogenous APE1 was detectable around day 6-8 and continued until at least day 14 in the WT and R237C cell lines. APE1 induction was further examined by immunofluorescence using cells that had been paraformaldehyde-fixed at day 10 after Dox removal. The expression of exogenous APE1 was clearly observed in the "On" state in the WT and R237C cell lines (as increased signal), but not in the RX control line, although some background endogenous mouse APE1 protein was observable in the different controls (Fig. 2B) . Lastly, APE1 induction was tested by measuring total AP endonuclease activity in whole cell extracts prepared from cells with (gene off) or without (gene on) Dox exposure. These studies revealed at least a twofold increase in total AP site incision activity in both the WT and R237C cell lines over the endogenous endonuclease activity, but no change in the RX cell line, approximately 5 passages ($10 days) after Dox removal (Fig. 2C ). The analysis collectively shows that overexpression of APE1 is occurring as expected in the WT and R237C cell lines, but not in the RX control line.
Consequences of WT or R237C APE1Overexpression
The above experiments describe the creation of independent cells lines that, in a regulated fashion, overexpress WT APE1 or the tumor-associated variant R237C. As noted above, these resources specifically allowed us to evaluate the role of altered APE1 expression in and the contribution of the tumor-associated R237C variant to a range of cancer cell phenotypes.
Growth Properties and Cell Cycle Distribution
We first examined proliferation by plating each cell line at equal density and allowing them to grow with or without Dox for 48 hr. After the cells reached approximately 90% confluency, each cell line was trypsinized and counted. The doubling time was calculated based on the standard online doubling calculator (see Materials and Methods section). Although there was some variability in the doubling times between the RX, WT, and R237C cell lines (Fig. 3A) , there was no significant difference in cell proliferation in conditions where the APE1 gene was off (black bar) or on (gray bar). The variation between the different lines appeared to be a unique feature of each clonal isolate, as this characteristic did not appear to change throughout the growth and maintenance of each cell line (i.e., from passage 5 to passage 25; unpublished observation).
To further examine the growth properties of each cell line, the cell cycle distribution was determined (Fig. 3B-D) . We found that each cell line maintained a similar cell cycle distribution in the presence or absence of Dox at passage 5. This phenotype persisted until passage 25, where we again found no obvious difference in cell cycle profile when the APE1 gene was on or off in the different cell lines. The only notable difference was between early passage 5 and late passage 25. Here, we observed a significant increase in the number of cells in G1 at passage 25 (and a concomitant decrease in S and G2 phase cells) for all lines, suggesting a slow-down of the cell cycle, which is likely attributed to the high passage number. In total, we found that overexpression of the WT or R237C APE1 protein did not overtly change proliferation or cell cycle profile with time.
DNA Damage Levels
We next determined the steady-state levels of DNA damage in the RX, WT, and R237C cell lines with or without Dox treatment. Since APE1 acts as the predominant AP endonuclease in mammals [Li and Wilson, 2014] , we measured specifically the levels of AP sites in isolated genomic DNA using the aldehyde-reactive probe technique (see Materials and Methods section). As reported in Figure  4A , we found that there was no difference in the level of total genomic AP sites for the WT and R237C cell lines after passage 5, whether the APE1 gene was on or off. The similar AP site levels were also observed at passage 25 (Fig. 4B) , indicating that overexpression of WT APE1 or the R237C variant does not affect the steady-state level of abasic damage. In addition, we used a high-throughput version of the single-cell neutral comet assay to measure single-and double-strand break damage. Consistent with the aldehyde-reactive probe assay, Figure 4C shows that there was no difference in genomic damage for each cell line, whether the APE1 gene was turned on or off. Thus, our data reveal that the level of endogenous DNA damage was not altered (positively or negatively) by overexpression of the WT or R237C APE1 protein.
Mitochondrial Functionality
Not only does APE1 contribute to maintaining nuclear genome integrity but it also localizes and operates in Environmental and Molecular Mutagenesis. DOI 10.1002/em Western blot analysis of human APE1 (hAPE1) expression in the presence (off) or absence (on) of Dox. Indicated is the day at which cells were harvested and protein extracts prepared following Dox removal (or not) from the medium. As evident, the in-house antibody raised against hAPE1 preferentially recognizes the exogenous human protein over the endogenous mouse protein. Lamin A/C was used as the protein loading control. (B) Immunostaining for hAPE1 expression. Cells (as indicated) were fixed at day 10 and probed with the APE1 antibody above. DAPI staining is included to identify the nucleus. A no-primary antibody treatment was used as a negative control to evaluate any nonspecific binding of the secondary antibody (not shown). (C) Total AP site incision activity of RX, WT, and R237C cell lines in the presence (off) or absence (on) of Dox. At day 10, cells were harvested and whole cell extracts prepared. AP endonuclease activity was measured using a classic radiolabeled DNA substrate. Shown is the incision efficiency (% product formed or incision) for the different conditions at 1 mg of whole cell extract. The values represent averages and standard deviations of at least three independent measurements. The paired t-test was performed to compare the off and on states, and statistically significant differences are indicated: *P < 0.05; **P < 0.005. mitochondria [Li et al., 2010; Barchiesi et al., 2015] . We therefore performed assays to measure mitochondrial function, specifically assessing (i) the amount of ROS by Mito-SOX, (ii) membrane potential using the drug TMRM, and (iii) mitochondrial content using MitoTracker. As shown in Figure 5 , we found that these three parameters showed an overlapping fluorescence profile in the RX, WT, and R237C cell lines, with (off) or without (on) Dox, at passage 5, consistent with similar mitochondrial phenotypes. The only exception was that after the WT APE1 gene was turned on, there was an increased level of ROS (Fig. 5,  MitoSOX) . To determine if this event persisted with time, Environmental and Molecular Mutagenesis. DOI 10.1002/em we examined the level of ROS after the WT APE1 protein was overexpressed for 25 passages. At that later time point, we no longer detected elevated levels of ROS (Supporting Information Fig. S4 ), implying that the overall mitochondrial health of the cells overexpressing WT APE1 was normal.
Cellular Transformation
Since other BER variants have been implicated in inducing transformation, we determined if overexpression of either WT APE1 or the tumor-associated R237C variant could promote a similar fate. In soft-agar experiments, which monitor anchorage-independent colony formation in semisolid media, we turned the APE1 gene on for 5, 10, 15, 20, or 25 passages to examine the transformation event with time. As shown (Fig. 6 ), for all cell lines (RX, WT, and R237C), the ratio of colonies formed in the on versus off condition remained around 1 during the course of the experiment, consistent with there being no clear effect of exogenous APE1 gene induction on transformation. This finding was corroborated using the focus formation assay, where, in brief, cells were grown for various passage numbers with the gene on or off, and then plated at low density in a T25 flask and allowed to grow for another 2 weeks. In these experiments, no foci or punctate were generated as a result of overexpression of WT or R237C APE1 protein (unpublished observation).
APE1Haploinsufficiency Leads To Impaired Cell Viability
As the counterpart to APE1 overexpression, we examined the consequences of targeted deletion of APE1 in human cells. Prior work using a floxed system in mouse cells [Izumi et al., 2005] or an siRNA knockdown strategy in human cells [Fung and Demple, 2005] revealed an essential function for the APE1 protein in cell viability. We aimed to use an unambiguous and definitive genetic approach in human cells, not complicated by potential siRNA off-target effects. We therefore used a locus-specific targeting vector that facilitated homologous recombination-mediated introduction of an engineered genomic deletion (see Materials and Methods section). The left homology arm included most of exon 1 through exon 3 (note: exon 1 is noncoding), as well as associated introns, whereas the right homology arm spanned exon 5 of the APE1 gene (Fig. 7A, part I) . This design created a deletion of exon 4, which encodes for amino acids L92 to I146 of APE1, including the metalcoordinating catalytic residue E96. Due to a loss of the reading frame, this deletion would be predicted to create a null allele. In the final construct, APE1 KO-SEPT (Fig.  7A) , the two homology arms flank the SEPT sequence, which contains a removable selectable marker that is promoterless [Topaloglu et al., 2005] .
Following infection of HCT116 with the rAAV, individual clones were selected and expanded for further analysis. Figure 7B shows the PCR genotyping of a small number of different clones following genomic DNA isolation. Our PCR strategy allows for the discrimination between the endogenous allele ($2.7 kb product) and the integrated KO allele ($4.1 kb), which includes the SEPT sequence. As shown (Fig. 7B) , clone number 7 has the properly integrated copy of the KO allele at one APE1 locus, a finding confirmed using additional primers that span the other homology arm (unpublished observation). This APE1 mutant cell line was designated HCT116 APE11/2 (or HT, for heterozygous KO). Western blotting indicated that the HT cell line expresses roughly half the amount of APE1 protein detected in the HCT116 parental line with two WT APE1 alleles (Fig. 7C) . The decreased expression of APE1 was associated with decreased AP endonuclease activity, suggesting that the loss of one allele caused a haploinsufficient phenotype (Fig. 7D) . To examine for a functional impact of APE1 reduction, we treated HCT116 APE11/2 cells with varying doses of MMS and H 2 O 2 for 1 hr before measuring cell viability (Fig. 7E) . These experiments revealed that the HT cell line was more sensitive to these DNA-damaging agents Environmental and Molecular Mutagenesis. DOI 10.1002/em than the parental WT cell line. We next attempted to excise the SEPT element by transient expression of the Cre recombinase, to proceed with a second round of targeting. However, we found that the HCT116 APE11/2 cells experienced reduced viability and apparent cell death after about 5 or 6 passages, indicating that even an approximately 50% reduction in the APE1 protein level is incompatible with continued human cell growth in culture.
Transcriptome Profile of APE1Haploinsufficient Human Cells
Despite the difficulty in maintaining the HCT116 APE11/2 cell line long-term in culture, we were able to harvest a sufficient number of cells at passage 5 (near the end of viability) to perform microarray experiments. Principal components analysis (PCA) of the global gene expression pattern for WT and HT HCT116 cells identified a clear separation in PCA space (Fig. 8) , indicative of a distinct and profound effect of APE1 deficiency on the transcriptome. Gene ontology analysis revealed that the functional categories most downregulated in HCT116 APE11/2 cells are related to transcription, protein and DNA binding, membranes, golgi apparatus, endoplasmic reticulum, endosome, apoptosis, and mitochondrion (Supporting Information Table S1 ). The most notable upregulated categories are associated with the ribosome and translation, nucleosome and chromosome organization, nucleolus, DNA replication, and cell division. The link to the nucleolus is particularly notable given the results regarding R237C above, as well as the published evidence that APE1 interacts with NPM1 and apparently functions to regulate ribogenesis [Vascotto et al., 2009; Poletto et al., 2014] . Supporting Information Table S2 provides a summary of the 40 most upregulated and downregulated genes in the APE1-deficient cells.
DISCUSSION
Several studies have implicated altered expression, intracellular localization, and/or amino acid composition of APE1 in the etiology of cancer [Li and Wilson, 2014; Thakur et al., 2015] . For example, using single strand conformation polymorphism analysis, Pieretti et al. [2001] discovered somatic APE1 mutations in endometrial tumor DNA that were not seen in the genome of nontumor tissue. One of the reported mutations produces a missense mutant protein, R237C, which we have previously shown to exhibit impaired AP-DNA complex stability (although normal AP endonuclease function on naked DNA), reduced 3 0 -exonuclease processing, and a defect in incising at AP sites within the context of pre-formed nucleosome-DNA or glycosylase-DNA complexes in vitro [Illuzzi et al., 2013; Hinz et al., 2015] . Our cell-based studies herein indicate that the somatic R237C variant has reduced ability to complement the MMS sensitivity and shortened survival of APE1 KO MEFs in culture relative to the WT protein, likely due to defects in the repair of AP sites and in the execution of specialized functions within the nucleolus. Coupled with the fact that R237C overexpression did not promote transformation of C127I cells (or have any noticeable effect on a number of cellular endpoints), our findings imply that the APE1 R237C variant is more likely to have played a part in affecting the risk of developing cancer or the etiology of the carcinogenic process (due to reduced repair capacity), than in promoting the initiation of carcinogenesis via a dominant mechanism.
Prior work has established that human BER variant proteins, particularly in DNA POLb, can induce transformation of mouse C127I cells, establishing proof-ofprinciple for the experimental method [Sweasy et al., 2005] . Nevertheless, we cannot completely exclude the possibility that this cross-species approach would be ineffective at revealing cancer-driving APE1 mutants. It is also likely that our model system does not fully recapitulate the cellular environment in the particular case of endometrial cancer. Still, in none of our assays to date have we seen a putative "dominant" effect of R237C (such as enhanced DNA substrate binding that might interfere with the subsequent steps of BER), consistent with the variant more likely operating as a reducedfunction susceptibility-type allele and not a promoter of the carcinogenic process. In line with this conclusion, while our article was in preparation, the Tell laboratory reported that the R237C variant was unable to complement the persistent activation of a DNA damage response seen in APE1-depleted human cells [Lirussi et al., 2016] . Environmental and Molecular Mutagenesis. DOI 10.1002/em It is generally believed that-excluding the situation in the CH12F3 mouse B-cell lymphoma line, which harbors three copies of the APE1 gene and presumably has an abnormally high level of chromosome recombination activity [Masani et al., 2013 ]-sufficient APE1 deficiency will lead to mammalian cell inviability. Such an outcome has been reported by the Demple, Mitra, and Tell laboratories in a number of cell models, including MEF, MCF7 breast adenocarcinoma, HCT116 colon carcinoma, U2OS osteosarcoma, TK6 lymphoblastoid, and HeLa cervical cancer cells [Fung and Demple, 2005; Izumi et al., 2005; Vascotto et al., 2009] . The work of Fung and Demple, using human cells and a small (or short) interfering RNA (siRNA) strategy, has in fact revealed that an APE1 protein level of around 40% or greater (of normal) is necessary to maintain normal cell proliferation, and that viability is dependent on APE1's function as a DNA repair nuclease [Fung and Demple, 2005] . In the case of MEFs, Mitra and colleagues used a floxed gene approach to delete both alleles and found that APE1 nuclease and APE11/2 (grey line) cell lines to MMS (top) and hydrogen peroxide (bottom). Cell viability (relative to the untreated sample) was determined using the CCK-8 viability assay at the indicated doses of genotoxin. Each value represents the average and standard deviation of three data points. The paired t-test was performed to compare WT versus HT cells, and statistically significant differences are indicated: *P < 0.05; **P < 0.005. acetylation-mediated gene regulatory roles were critical for survival [Izumi et al., 2005] . However, in these studies, it was not shown that the complementing site-specific mutant protein was expressed, raising uncertainty about their overall conclusions. Our observation that HCT116 cells, which had been targeted by a clean genetic approach (i.e., no off-target effects), cannot be cultured long-term after deletion of just a single APE1 allele is consistent with the idea that haploinsufficiency in APE1 is poorly tolerated in human cells in culture. Interestingly, although mice with only one copy of APE1 are viable, these haploinsufficient animals are born at reduced frequencies and exhibit increased risk of both spontaneous and stress-induced pathologies [Meira et al., 2001] .
Our gene expression analysis of the HCT116 APE11/2 cells near the end of their viability revealed several noteworthy changes. In particular, genes related to processes such as chromosome assembly, transcription and translation, signal transduction, intracellular trafficking, metal homeostasis, mitochondrial and biosynthetic activities, cell growth, and apoptosis were differentially altered in the APE1-deficient background. It is our interpretation that the lack of sufficient APE1 results in a cascade of events that ultimately lead to a compensatory response that aims to either maintain cell viability or promote cell death via a variety of possible apoptotic mechanisms. Using 2D polyacrylamide gel electrophoresis coupled with matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) to identify differentially expressed proteins, Vascotto et al. [2009] similarly found components of signal transduction, cytoskeletal structure, intracellular trafficking and metabolism to be most significantly deregulated in APE1-deficient HeLa cells. A more recent study examining global gene expression in APE1-deficient and APE1-complemented MEFs reported that the protein positively regulates components of the OXPHOS system, indicating a direct role in regulating mitochondria activity and the general state of the cellular metabolic network [Suganya et al., 2015] . While the precise details among the published studies vary, perhaps because of the stage at which the expression analysis was performed, the overall results implicate alterations in cell cycle regulation, mitochondrial activity and the general cellular operations as a means to rescue the cell or activate cell death responses. Given that it is unlikely that null or near null APE1 individuals are present in the population, it becomes important to examine whether subjects with reduced APE1 function exist and whether they exhibit susceptibility to relevant pathologies. Prior studies have indicated an approximately twofold variation in total AP endonuclease activity, indicating that there may indeed exist impaired APE1 individuals [Wilson et al., 2011] . Besides determining the prevalence and degree of APE1 variation in the population, and its relationship to disease risk, understanding the molecular mechanism(s) underlying the variability will be just as important. In addition, more exhaustive searches for rare APE1 mutant alleles (presumably somatic mutations) that may operate dominantly in disease manifestation, potentially akin to what has been described for the artificial APE1 double mutant, ED (mutations at functional residues E96 and D210) [McNeill and Wilson, 2007; McNeill et al,. 2009 ], should continue in today's genomics-rich environment.
